T cells: Costimulatory Receptors

T cell activation requires engagement of both the T cell receptor and a co-stimulatory molecule. Lack of a co-stimulatory signal can result in T cell anergy, deletion, or immune tolerance. Find the latest research on T cell co-stimulatory receptors here.

July 3, 2020
Open Access

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

Iñaki EtxeberriaIgnacio Melero
July 2, 2020
Open Access

CD8+ CD57+ T cells exhibit distinct features in human non-small cell lung cancer

Journal for Immunotherapy of Cancer
Bing HuangLequn Li
July 4, 2020

Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer

Anti-cancer Agents in Medicinal Chemistry
Navgeet KaurRakesh K Sindhu
June 24, 2020
Open Access

cGAS-STING, an important pathway in cancer immunotherapy

Journal of Hematology & Oncology
Minlin JiangCaicun Zhou
June 26, 2020

The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma

Anvar SoleimaniMahmoud Reza Jaafari
July 6, 2020

Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer

Seminars in Cancer Biology
Nicola GaynorDenis M Collins
June 25, 2020

Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine

Journal of Controlled Release : Official Journal of the Controlled Release Society
Maryam EsmailyFarhad Jadidi-Niaragh
June 27, 2020
Open Access

Tumor Mutational Burden, Toxicity and Response of Immune Checkpoint Inhibitors (ICIs) Targeting PD(L)1, CTLA-4, and Combination: A Meta-Regression Analysis

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Arsen OsipovMark Yarchoan
June 25, 2020

Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients

Cancer Immunology, Immunotherapy : CII
Yusuke OmuraMasato Kusunoki
June 28, 2020

Soluble immune checkpoints CTLA-4, HLA-G, PD-1 and PD-L1 are associated with endometriosis-related infertility

American Journal of Reproductive Immunology : AJRI
Budi SantosoFadhil Ahsan

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved